New England Biolabs Expands Liquid Biopsy Toolkit with Cell-Free RNA Extraction Kit
Event summary
- New England Biolabs launched the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit on August 4, 2026.
- The kit isolates low-abundance cfRNA from biofluids like plasma and cerebrospinal fluid.
- It addresses DNA carryover and small RNA loss with chaotropic salt-based chemistry and lyophilized DNase.
- The product complements NEB's existing cfDNA extraction kit and sequencing solutions.
The big picture
While cell-free DNA has dominated liquid biopsy applications, NEB's new kit positions cfRNA as a complementary analyte offering tissue-specific insights. This launch reflects the growing industry recognition of cfRNA's potential in tracking disease progression and treatment response. The product fits into NEB's strategy of providing end-to-end solutions for nucleic acid profiling, competing with larger players in the molecular diagnostics space.
What we're watching
- Adoption Pace
- How quickly researchers will integrate cfRNA analysis alongside established cfDNA workflows.
- Competitive Response
- Whether rivals like Thermo Fisher or Qiagen will accelerate their own cfRNA extraction solutions.
- Clinical Translation
- The speed at which this technology moves from research use to diagnostic applications.
Related topics